Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

Innovative Evaporator Technology Protects Samples & Increases Productivity

Published: Wednesday, November 07, 2012
Last Updated: Wednesday, November 07, 2012
Bookmark and Share
Proprietary SampleGuard™ temperature control technology on Genevac HT Series II Evaporators enables them to automatically detect when samples are dry and then shut down - safeguarding valuable samples from potential thermal degradation.


Combined with Genevac's continuous running condensers, SampleGuard™ allows easy unattended operation offering the possibility of significant increases in productivity through use of overnight evaporation runs.

 Comprising two thermocouples and a unique sample temperature radio transmitter, SampleGuard™ provides real time feedback enabling unmatched accuracy in controlling of actual sample temperatures. SampleGuard™ probes can measure temperature at any point in the sample holder. Either one or two probes can be used to accurately and reliably determine end-of-run, enabling the system to be easily set for optimal performance and automatic shutdown. 

HT Series II Solvent Evaporators offer leading edge features that provide superior sample protection, flexibility for multiple applications, consistency of results, robust build quality, ease-of-use, rapid high-throughput results and low maintenance.

For further information please contact Genevac on telephone +44-1473-240000 / +1-845-255-5000 or email

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Genevac Consolidate Evaporator & Freeze Dryer Sales Channels in the UK
Company appoints BioPharma Process Systems as exclusive UK distributor.
Thursday, May 15, 2014
GenVec Announces Manufacturing Agreement for TNFerade™
The agreement will cover technology transfer, scale-up, and validation of the manufacturing process for TNFerade through cGMP consistency lots.
Friday, January 25, 2008
Genevac Launches new Information-rich Website
According to Genevac its new website is an information hub for evaporation, concentration and lyophilization.
Tuesday, November 27, 2007
Genevac Ltd. Acquired by Riverlake Partners
The acquisition of Genevac from Thermo Scientific will play a critical role in Riverlake's SP Industries for future growth and expansion.
Friday, April 13, 2007
New Approach to Compound Library Maintenance
The report describes a new high throughput process to produce compound libraries as dry films that have been validated for long-term storage.
Thursday, April 06, 2006
Genevac Moves on WEEE Compliance
As a result of upgrade and trade-in schemes over the last year, Genevac took back and has recycled 150 evaporators.
Tuesday, March 21, 2006
High-throughput Evaporation of Strongly Acidic Chemicals
The new version of the HT-12 Series II system has been introduced to provide laboratories with a highly efficient and safe means of routinely removing strongly acidic chemicals from their samples.
Thursday, July 14, 2005
Genevac DD- 4 & Metz Syn10 on Display at Labautomation 2002

Monday, January 14, 2002
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos